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Aim. To develop an alternative method for the quantitative determination of the benzalkonium chloride content as an active 
pharmaceutical ingredient in the disinfectant solution “CUTASEPT® F”.
Materials and methods. The method is based on the ability of benzalkonium chloride to inhibit the enzymatic hydrolysis of 
acetylcholine by acetylcholinesterase. The reaction rate is assessed by the non-hydrolyzed acetylcholine residue, which is 
determined by the amount of peracetic acid produced during the interaction with the excess of the hydrogen peroxide solu-
tion. The indicator reaction is the interaction of p-phenetidine with peracetic acid that leads to the formation of 4,4’-azoxy-
phenetole with λmax = 358 nm (log10 ε = 4.2).
Results and discussion. As a result of the research conducted the linear dependence of the degree of inhibition of the enzy-
matic hydrolysis of acetylcholine (U, %) on the concentration of benzalkonium chloride was determined in the concentra-
tion range of (0.5 – 7.0) × 10–6 mol L-1 with the correlation coefficient of 0.999. The limit of quantitation was 1.9 × 10–6 mol L-1.
Conclusions. As a result of the research conducted the kinetic enzymatic method for the quantitative determination of benzalkonium 
chloride has been developed by its inhibitory effect in the biochemical reaction of acetylcholine hydrolysis. This method is 
fast, cheap and easy to perform, does not require expensive equipment, and available for use in the field.
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Ензимний метод кількісного визначення бензалконій хлориду в антисептичному розчині 
«КУТАСЕПТ® Ф»
Анотація 
Мета. Розробити альтернативний метод кількісного визначення вмісту бензалконій хлориду як активного фармацев-
тичного інгредієнта в дезінфекційному розчині «КУТАСЕПТ® Ф».
Матеріали та методи. Метод заснований на здатності бензалконій хлориду пригнічувати гідроліз ацетилхоліну за по-
середництва ензиму холінестерази. Швидкість реакції оцінюють за залишком негідролізованого ацетилхоліну, який 
визначають за кількістю пероцтової кислоти, утвореної в результаті взаємодії ацетилхоліну та надлишку гідроген 
пероксиду. Індикаторною реакцією є взаємодія n-фенетидину з пероцтовою кислотою, що призводить до утворення 
4,4’-азоксифенетолу з λmax = 358 нм (log10 ε = 4,2).
Результати та їх обговорення. У результаті проведених досліджень отримано лінійну залежність ступеня інгібування швидкості 
ензимного гідролізу ацетилхоліну (U, %) від концентрації бензалконій хлориду в межах концентрацій (0,5 – 7,0) × 10–6 моль л-1 
з коефіцієнтом кореляції 0,999. Межа кількісного визначення становила 1,9 × 10–6 моль л-1.
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Висновки. У результаті проведених досліджень розроблено кінетико-спектрофотометричну методику кількісного 
визначення бензалконій хлориду за його інгібіторною дією в біохімічній реакції гідролізу ацетилхоліну. Цей метод 
швидкий, дешевий та простий у виконанні, не потребує коштовного обладнання, доступний для використання 
в «польових» умовах. 
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■ Introduction
A rapid spread of coronavirus infections (SARS- 
CoV-2) in the world stimulated mass efforts by 
governments, local authorities and healthcare 
institutions on conducting disinfection campaigns 
of state and public institutions [1]. The World 
Health Organization recommended the extensive 
use of disinfectants and antiseptics. Therefore, 
an effective drug “CUTASEPT® F” (BODE Chemie 
GmbH, Germany) has become especially wide-
spread. It is based on alkyldimethylbenzylam-
monium chloride. “CUTASEPT® F” according to me- 
thodical recommendations [2] is a high-perfor-
mance fast-acting solution with the prolonged 
action, it guarantees a long-term protection of 
a patient at a long-term operation, does not irri-
tate the skin, provides degreasing and cleaning, 
promotes effective fixing of a film after drying. 
A disinfectant and at the same time an anti-
septic “CUTASEPT® F” was designed for the pre-
and postoperative treatment of the skin and sur-
gical sutures; disinfection of the patients’ skin 
before invasive procedures: injections, punctures, 
blood sampling; disinfection of the skin with mi-
nor injuries; hygienic and surgical disinfection 
of the skin of the hands of the medical staff of 
treatment and prevention institutions in emer-
gency situations; rapid disinfection of surfaces, 
medical devices, including tools and gloves in 
emergency situations.
The drug has the bactericidal, tuberculocidal, 
fungicidal and virucidal action. This makes it 
especially popular during coronavirus infection 
(SARS-CoV-2) in the world. “CUTASEPT® F” is 
active against coronaviruses in a concentration 
of ≤ 1 % when exposed to less than for 1 min [2, 3].
According to the guidelines, the quantitative 
content of benzalkonium chloride is determined 
by the method of titration with sodium tetraphe-
nylborate in the aqueous medium at an approxi-
mate рН value of 3.4. The potentiometric deter-
mination of the titration endpoint is used [2, 4]. 
The disadvantage of this method is that even though 
the amalgam electrode can withstand many hund- 
reds of titrations, but, if necessary, one needs to 
repeat the amalgamation [2].
As an alternative to the existing method of 
quantifying the content and in addition to the va- 
luable chromatographic methods described in the li- 
terature [5 – 11] we have proposed a relatively 
cheap, affordable, fast kinetic photometric method 
for determining the quantitative content of ben-
zalkonium chloride in the disinfectant solution 
“CUTASEPT® F”.
The latter is a quaternary ammonium com-
pound (QAC), which is capable of inhibiting the en-
zyme acetylcholinesterase (AChE). In turn, a chan- 
ge in the activity of AChE causes a change in 
the amount of unreacted acetylcholine (АСh) in 
the enzymatic hydrolysis reaction (Scheme). Addi-
tion of hydrogen peroxide to the unreacted ACh 
leads to the formation of an equivalent amount 
of peracetic acid. The latter can react with р-phe- 
netidine giving a colored product, and it allows 
estimating the quantitative content of peracetic 
acid and subsequently the amount of АСh. The me- 
thod involves the photometric detection of the co- 
lored product at λmax = 358 nm (log10 ε = 4.2).
■ Materials and methods
Reagents and equipment 
Benzalkonium chloride (BAC), 50 % water so-
lution (Akzo Nobele, Surface Chemistry AS, Sweden) 
is a mixture of benzyl(dodecyl)dimethyl ammonium 
chloride (approx. 65 %) and benzyl(tetradecyl)di-
methyl ammonium chloride (approx. 35 %).
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p-Phenetidine, 98 % (Sigma-Aldrich); p-Phene- 
tidine hydrochloride was prepared by dissolution 
of p-phenetidine in chloroform followed by pre-
cipitation of the salt by gaseous HCl.
Acetylcholine chloride, 0.2 g of the substance 
in an ampoule, is of pharmaceutical grade (State 
Science Center of Virology and Biotechnology 
“Vector”, Russia).
“CUTASEPT® F”, 50 mL (BODE Chemie GmbH, 
Humburg) is an antiseptic and disinfectant solu-
tion. The composition of the drug, wt. %, is as fol-
lows: 2-propanol – 60.0 – 66.0; benzalkonium chlo-
ride – 0.020 – 0.030; dyes – orange-yellow S (E110), 
quinolone yellow (E104), diamond black BN (E151); 
water – up to 100.0 mL.
Disodium hydrogen phosphate dodecahydrate, 
Na2HPO4∙12H2O, puriss. p.a. (“ReaChem”, Kharkiv, 
Ukraine), and a dry cholinesterase from horse 
serum (SMU “Biomed”, Russia), 80 mg (VI class), 
activity 22 AU/mg were applied. The catalytic 
activity of 1 activity unit (AU) is manifested by 
such an amount of this enzyme preparation that 
converts 1 µmole of this substrate in 1 min un-
der given reaction conditions.
Stabilized hydrogen peroxide, 30 – 40 % solu-
tion, puriss. p.a. (LLC Inter-Synthes, Boryslav, 
Ukraine) was used; the precise content of hydrogen 
peroxide was determined according to the State 
Pharmacopoeia of Ukraine [12].
High purity double distilled water was used 
during our experiments.
The absorbance measurements were perfor- 
med on a colorimeter (CFC-2) (Zagorsky Optical 
and Mechanical plant, Russia) using quartz cells 
with the width of 1 cm.
The pH measurements were performed with 
a combined glass electrode (SP20B) together with 
an EAL-1М3.1 reference standard silver chloride 
electrode.
Preparation of the test solution 
4.00 mL of “CUTASEPT® F” was transferred 
into a 1000.00 mL volumetric glass flask, and 
double-distilled water (10 mL) was added, the con-
tent was then mixed and diluted to the volume 
with the same solvent. The concentration was 
2.8 × 10–5 mol L-1.
Preparation of the work standard solution 
The work standard solution was prepared using 
double-distilled water. 0.09910 g of the BAC stan- 
dard solution (50.0 %) was quantitatively trans-
ferred into a 500.00 mL volumetric flask and di-
luted to the volume with water. 1.00 mL of this 
solution was transferred into a 10 mL volumetric 
flask and was diluted to the volume with water.
Preparation of 0.2 M phosphate buffer 
solution (pH 8.35) 
Disodium hydrogen phosphate dodecahydrate 
(35.75 g) was dissolved in 500 mL of double-dis-
tilled water, and 0.1 M solution of hydrochloric 
acid (19 mL) was then added. The pH of the final 
solution was controlled potentiometrically.
Preparation of 10 % hydrogen peroxide 
solution 
The solution was prepared by dilution of hydro-
gen peroxide with the required amount of double- 
distilled water. The content of hydrogen peroxide 
Scheme. The method of the quantitative determination of benzalkonium chloride
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in 10 % work solution was determined perman-
ganatometrically [12].
Preparation of 1 % p-phenetidine hydro-
chloride solution 
1.00 g of p-phenetidine hydrochloride was dis-
solved in 80 mL of double-distilled water in a 100 mL 
volumetric flask and diluted to the volume with 
the same solvent.
Preparation of cholinesterase (ChE) so-
lution 
In a flask containing a dry powder of cholines- 
terase (80 mg) double-distilled water (10 mL) 
was added, the flask was transferred to a ther-
mostat for 10 min at a temperature of 37 – 40 ºС.
Preparation of acetylcholine chloride 
solution (ACh) 
The ampoule content (0.2 g of ACh) was dissol- 
ved in 20 mL of double-distilled water. An am-
poule was opened, 4.0 mL of water was pipetted 
and added to the ampoule and then shaken un-
til acetylcholine was completely dissolved. Then 
the ACh solution was transferred into a 200 mL 
volumetric flask and diluted to the volume with 
double-distilled water.
The general procedure for the quantita-
tive determination of benzalkonium chlori- 
de in the antiseptic solution “CUTASEPT® F” 
The first part: 10.0 mL of 0.2 M phosphate 
buffer solution (pH = 8.3) was transferred into 
a 20 mL graduated test-tube with a ground stop-
per, 1 % ACh solution (1.0 mL) and 10 % hydrogen 
peroxide solution (2.0 mL) were consecutively ad- 
ded, and the stopwatch was started. After that, 
the solution was shaken thoroughly and thermos- 
tated for 10 min. Then 1 % p-phenetidine hydro-
chloride solution (1.0 mL) was added to the test 
tube and diluted to the volume with double-dis-
tilled water. The stopwatch was started again, 
and the solution was scanned photometrically 
every minute over the period of 15 min on a photo-
electric colorimeter; a color filter No. 2 and a 1.0 cm 
cuvette were used. The solution containing only 
0.2 M phosphate buffer (10.0 mL, pH = 8.3) was 
used as a reference solution. The rate of the re-
action [(ACh + H2O2) + p-Ph] (tgαVmax, min–1) was 
determined as a slope of the kinetic curve opti-
cal density (A) vs time (t, min).
The second part: 0.2 M phosphate buffer so-
lution (10.0 mL, pH = 8.3) was transferred into 
a 20 mL graduated test tube with a ground stopper. 
After that, the cholinesterase solution (2.0 mL) 
was added followed by 1.0 mL of 1 % acetylcholine 
solution. The mixture was shaken thoroughly 
and thermostated for 10 min. Then 10 % hydro-
gen peroxide solution (2.0 mL) was introduced 
into the test tube while stirring. The mixture was 
shaken thoroughly and kept for 10 min in a ther-
mostat. Then 1 % p-phenetidine hydrochloride so-
lution (1.0 mL) was added and diluted to the volume 
with double-distilled water. The stopwatch was 
started, and every minute the solution was scan- 
ned photometrically for 15 min on a photoelectric 
colorimeter; a color filter No. 2 and a 1.0 cm cu-
vette were used. The solution containing only 
0.2 M phosphate buffer (10.0 mL, pH = 8.3) was 
used as a reference solution. The rate of the reac-
tion [(ChE + ACh) + H2O2 + p-Ph] (tgαmin, min–1). 
was determined as a slope of the kinetic curve 
optical density (A) vs time (t, min).
The third part: 0.2 M phosphate buffer solu-
tion (10.0 mL, pH = 8.3) was transferred into 
a 20 mL graduated test tube with a ground stopper. 
The accurate volumes of the test solution of BAC 
were added to the test tube. The cholinesterase 
solution (2.0 mL) was added while stirring, a stop-
watch was started; each solution was shaken 
thoroughly and thermostated for 10 min. Then 
1 % acetylcholine solution (1.0 mL) was quickly 
added, and a stopwatch was started, shaken thoro- 
ughly and thermostated for 10 min again. After 
that, 10 % hydrogen peroxide solution (2.0 mL) 
was added, the mixture was kept in the thermos- 
tat for 10 min, and then 1 % p-phenetidine hydro-
chloride solution (1.0 mL) was added and dilu- 
ted to the volume with double-distilled water. 
The stopwatch was started, and the solution was 
scanned photometrically on a photoelectric colo- 
rimeter every minute for 15 min; a color filter 
No. 2 and a 1.0 cm cuvette were used. Solution con-
taining 0.2 M phosphate buffer (10.0 mL, pH = 8.3) 
was used as a reference solution. The rate of 
the reaction [[(ChE + BAC) + ACh] + H2O2 + p-Ph] 
(tgαci, min–1) was determined as a slope of the ki- 
netic curve optical density (A) vs time (t, min).
The calibration graph procedure
The performance of the method proposed was 
verified on samples containing from 1.00 mL to 
5.00 mL of the BAC work standard solution ac-
cording to the General procedure.
The degree of inhibition of the enzymatic hydro- 
lysis of acetylcholine (U, %), in the presence of 









× 100 % ,
where tgαVmax (min–1) – is the rate of the p-phene- 
tidine oxidation reaction with peroxyacetic acid 
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formed in the reaction of acetylcholine perhydro- 
lysis in the absence of the enzyme (ChE) and the in- 
hibitor (BAC);
tgαmin (min–1) – is the rate of the p-phenetidine 
oxidation reaction with peroxyacetic acid formed 
in the reaction of perhydrolysis of unreacted ACh 
in the presence of the enzyme (ChE) and the ab-
sence of the inhibitor (BAC);
tgαci (min–1) – is the rate of the p-phenetidine oxi-
dation reaction with peroxyacetic acid formed in 
the reaction of perhydrolysis of unreacted ACh 
in presence of the enzyme (ChE) and the inhibi-
tor (BAC) with the concentration сі.
■ Results and discussion
Parameters affecting the performance of the me- 
thod proposed were studied to reach the optimum 
working conditions and reagent concentrations [13]. 
Once the optimum working conditions were de-
termined, we evaluated the enzymatic kinetic 
photometric method with respect to its linearity, 
limit of determination (LOD), accuracy, and pre-
cision.
Kinetic curves (Figure 1) of the indicator reac-
tion of p-phenetidine oxidation by hydrogen per-
oxide in the presence of the systems mentioned 
above (AСh or ACh + ChE or ACh + (ChE + BAC)) 
were linear within the first 15 minutes of the op- 
tical density measurements.
This enables the use of angular coefficient of 
slope (tgα, min–1) of the derived kinetic lines, built 
in the optical density (A) vs time (t, min) coordi-
nates, as a value of the analytical signal corres- 
ponding to the certain content of the inhibitor in 
a sample for assessing the reaction rate.
The calibration graph was constructed using 
the average of 5 values of the degree of inhibi-
tion of the enzymatic hydrolysis of acetylcholi- 
ne (U, %) corresponded to a definite concentra-
tion of the BAC solution (Figure 2). The equa-
tion of the calibration dependence was found 
to be U(%) = 0.7434 × 106c + 5.54 (where c is 
the BAC concentration, mol L-1; b = 0.7434 × 106; 
a = 5.54 mol L-1).
The calibration curve was linear within the 
concentration range of (0.5 – 7.0) × 10–6 mol L-1 of 
BAC with a correlation coefficient of 0.999, LOD 






















Figure 1. Kinetic curves of p-phenetidine oxidation by hydrogen peroxide in the presence of the system: 1 – ACh + ChE,  
2 – 6 – ACh + (ChE + BAC), 7 – AСh; w(ACh) = 0.1 %; ChE = 22 AU/mg; c(BAC), 10–6 mol L-1: 2 – 1.4, 3 – 2.8, 4 – 3.4, 5 – 5.6, 6 – 7.0
 
Table 1. The assessment of accuracy and precision of the BAC 
concentration determination in the standard solutions
BAC Taken BAC Found[a] RSD, % Recovery, % texp(ttable = 2.78)c × 10–6, mol L-1
2.80 2.83 ± 0.10 2.95 101.0 0.82
4.20 4.22 ± 0.08 1.57 100.5 0.68
5.60 5.65 ± 0.06 0.86 100.9 2.22
7.00 7.05 ± 0.60 0.71 100.7 2.24
Note: [a] n = 5; P = 0.95 %
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In order to estimate the accuracy and pre-
cision of the method proposed, BAC standard 
solutions with the concentrations of 2.8 × 10–6; 
4.2 × 10–6; 5.8 × 10–6 and 7.0 × 10–6 mol L-1 were 
analyzed according to the General procedure. 
For this purpose, five replicate determinations 
of each concentration were carried out. In each 
of 4 graduated test tubes with a ground stopper 
0.2 M phosphate buffer (8.0 mL) and 2.00 mL, 
3.00 mL,  4.00 mL and 5.00 mL of the BAC so-
lution, respectively, were added. The mixtures 
obtained were analyzed according to the General 
procedure.  The results of the BAC concentration 
assay in the standard solutions are presented 
in Table l. As one can see, the recovery percent 
ranged from 100.70 % to 101.00 % (texp < ttabl), while 
the relative standard deviations ranged from 
0.71 % to 2.95 %.
The procedure of the BAC concentration assay 
of “CUTASEPT® F” was as follows. 1.00 mL of 
“CUTASEPT® F” was transferred into a 5 mL vo- 
lumetric calibrated flask and diluted to the volu- 
me with double-distilled water for the sample solu-
tions preparation. The known volumes of the samp- 
le solution (2.00 mL) were analyzed by the kine- 
tic-photometric method proposed (according to 
the General procedure). In each of 4 test tubes with 
a ground stopper 0.2 M phosphate buffer (8 mL), 
2.00 mL of the “CUTASEPT® F” sample solution 
and 2.00 mL, 3.00 mL, 5.00 mL of the BAC work 
standard solution were added, respectively, one 
test-tube remained untouched. The solutions were 
analyzed according to the General procedure. Each 
test was repeated three times. The results com-
piled in Table 2 show that recovery was in the ran- 
ge of 100.79-101.19 %. It indicates that being 
a constituent of “CUTASEPT® F”, 2-propanol did 
not interfere with the kinetic photometric deter-
mination of BAC. Thus, the method proposed al-
lows us to obtain accurate and reliable results: 
(texp < ttable) and RSD < 2.8 %.
■ Conclusions
The kinetic photometric method can be ap-
plied for the enzymatic determination of benzal 
konium chloride in the antiseptic and disinfec-
tion solution “CUTASEPT® F”. The method pro-
posed is inexpensive, rapid and sensitive. The ana- 
lytical parameters, sensitivity, precision, and ac-
curacy allow this method to be an alternative to 
chromatographic methods.





















Figure 2. The calibration graph of the dependence of the degree of inhibition of the enzymatic hydrolysis of acetylcholine (U, %)  
on the concentration of the BAC solution
 
 
Table 2. The assessment of accuracy and precision of the BAC concentration determination in “CUTASEPT® F” solutions
BAC taken,  
c × 105 mol L-1
BAC added,
c × 105 mol L-1
BAC found,
c × 106 mol L-1
Found BAC added[a],
(X ± ΔX) × 106, mol L-1 RSD, %
Recovery of 
BAC added, % texp/ttable
2.80 – 2.81 – – – –
2.80 2.80 5.72 (2.82 ± 0.10) 2.83 100.7 1.40/2.78
2.80 4.20 7.30 (4.27 ± 0.06) 1.23 101.7 2.33/2.78
2.80 5.60 8.35 (5.07 ± 0.08) 1.07 101.7 1.85/2.78
Note: [a] the mean of three measurements (P = 0.95)
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